| RS748454316 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS748454609 |
PRICKLE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, progressive myoclonic |
| RS748454643 |
IFT43
|
Health Risk |
Pathogenic |
— |
| RS748455192 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, EEM syndrome |
| RS748455430 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS748455832 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS74845752 |
SLC6A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Behavior disorder, Behavior disorder |
| RS748457992 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS748458910 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS748459210 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS748459670 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Stickler syndrome |
| RS748460226 |
HESX1
|
Health Risk |
Pathogenic |
Septo-optic dysplasia sequence, GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES |
| RS748461293 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS748464075 |
C9
|
Health Risk |
Pathogenic |
— |
| RS748464182 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, FREM1-related disorder |
| RS748464757 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS74846539 |
SGCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Qualitative or quantitative defects of delta-sarcoglycan, Cardiomyopathy |
| RS748465849 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS748466015 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS748466861 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, Charcot-Marie-Tooth disease axonal type 2O |
| RS748467821 |
SRCAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Developmental delay |
| RS748468302 |
MMP13
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal anadysplasia 1, autosomal dominant |
| RS748468371 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS748468831 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial calcification, generalized |
| RS748470273 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS748471297 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS748471791 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Inborn genetic diseases |
| RS748471942 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Nephronophthisis |
| RS748473096 |
TBXAS1
|
Health Risk |
Pathogenic |
— |
| RS748473278 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS748475674 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS748475714 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS748475805 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Immunodeficiency 35 |
| RS748475864 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Inborn genetic diseases |
| RS748476974 |
TWIST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sweeney-Cox syndrome, Saethre-Chotzen syndrome |
| RS748477031 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS748477839 |
GANAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 3 with or without polycystic liver disease, Inborn genetic diseases |
| RS748478445 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Early-onset myopathy with fatal cardiomyopathy |
| RS748478593 |
PRPH2
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 3, Vitelliform macular dystrophy 3 |
| RS748479655 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS748480363 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS748480664 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS748480687 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS748484883 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS748487419 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Retinal dystrophy |
| RS748487774 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniosynostosis syndrome, Ectopia lentis 2 |
| RS748488870 |
CARD10
|
Health Risk |
Pathogenic |
Immunodeficiency 89 and autoimmunity, Immunodeficiency 89 and autoimmunity |
| RS748491031 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS748491132 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Brugada syndrome 5 |
| RS748491825 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS748492214 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS748494624 |
MASP1
|
Health Risk |
Likely pathogenic |
— |
| RS748495327 |
TBCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoparathyroidism-retardation-dysmorphism syndrome, Hypoparathyroidism-retardation-dysmorphism syndrome |
| RS748495610 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Inborn genetic diseases |
| RS748496499 |
DNAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 16, Primary ciliary dyskinesia 16 |
| RS748497823 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS748497834 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS748499180 |
RAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS748500676 |
MPV17
|
Health Risk |
Likely pathogenic |
Uterine corpus endometrial carcinoma, Uterine corpus endometrial carcinoma |
| RS748500860 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS748501516 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS748501800 |
SPTBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay, impaired speech |
| RS748501827 |
VPS13C
|
Health Risk |
Likely pathogenic |
— |
| RS748502176 |
CUX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypertrophic cardiomyopathy |
| RS748503586 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS748504264 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS748504948 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS748505119 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS748505216 |
PMPCB
|
Health Risk |
Likely pathogenic |
Multiple mitochondrial dysfunctions syndrome 6, Multiple mitochondrial dysfunctions syndrome 6 |
| RS748505843 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS748506175 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-hypogonadism-choroidal dystrophy syndrome, Hereditary spastic paraplegia 39 |
| RS748506439 |
NAA60
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS748506953 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS748507521 |
DNAH8
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS748508287 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS748508322 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS748508725 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS748510210 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS748510599 |
KIF14
|
Health Risk |
Pathogenic |
— |
| RS748510736 |
NLRC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 4, Periodic fever-infantile enterocolitis-autoinflammatory syndrome |
| RS748511141 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS748511475 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS748511528 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Type 2 collagenopathy |
| RS748512916 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS748513242 |
GCM2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Hypoparathyroidism |
| RS748513310 |
NBN
|
Health Risk |
Pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS748513464 |
ADCY10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS748514374 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS748514860 |
TTC21B
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 4, Nephronophthisis 12 |
| RS748515167 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS748515506 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 1 diabetes mellitus 10, Immunodeficiency due to CD25 deficiency |
| RS748516187 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS748516947 |
MYH11;NDE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS748517635 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, SCN4A-related non-dystrophic myotonia |
| RS748518694 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS748519030 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS748519147 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS748521267 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS748522054 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS748522633 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |